These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18045062)

  • 1. Role of focal adhesion kinase in human cancer: a potential target for drug discovery.
    Han EK; McGonigal T
    Anticancer Agents Med Chem; 2007 Nov; 7(6):681-4. PubMed ID: 18045062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of focal adhesion kinase (FAK) reduction by small inhibitory RNAs.
    Han EK; Mcgonigal T; Wang J; Giranda VL; Luo Y
    Anticancer Res; 2004; 24(6):3899-905. PubMed ID: 15736429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Focal adhesion kinase: a potential target in cancer therapy.
    van Nimwegen MJ; van de Water B
    Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAK inhibitors in Cancer, a patent review.
    Lv PC; Jiang AQ; Zhang WM; Zhu HL
    Expert Opin Ther Pat; 2018 Feb; 28(2):139-145. PubMed ID: 29210300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase.
    Tsutsumi K; Kasaoka T; Park HM; Nishiyama H; Nakajima M; Honda T
    Int J Oncol; 2008 Jul; 33(1):215-24. PubMed ID: 18575768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of FAK inhibitors with a 5-fluoro-7H-pyrrolo[2,3-d]pyrimidine scaffold as anti-hepatocellular carcinoma agents.
    Tan H; Liu Y; Gong C; Zhang J; Huang J; Zhang Q
    Eur J Med Chem; 2021 Nov; 223():113670. PubMed ID: 34214842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FAK expression regulation and therapeutic potential.
    Li S; Hua ZC
    Adv Cancer Res; 2008; 101():45-61. PubMed ID: 19055942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal adhesion kinase as a cancer therapy target.
    Golubovskaya VM
    Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
    Schwock J; Dhani N; Hedley DW
    Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
    Chauhan A; Khan T
    Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
    Wang GJ; Ma YP; Yang Y; Zhang N; Wang W; Liu SY; Chen LJ; Jiang Y; Zhao X; Wei YQ; Deng HX
    Cell Biol Int; 2011 Aug; 35(8):841-8. PubMed ID: 21247411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of FAK in tumor metabolism and therapy.
    Zhang J; Hochwald SN
    Pharmacol Ther; 2014 May; 142(2):154-63. PubMed ID: 24333503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.
    Yoon H; Dehart JP; Murphy JM; Lim ST
    J Histochem Cytochem; 2015 Feb; 63(2):114-28. PubMed ID: 25380750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    Mol Cancer; 2005 Oct; 4():37. PubMed ID: 16209712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal adhesion kinase and cancer.
    Golubovskaya VM; Kweh FA; Cance WG
    Histol Histopathol; 2009 Apr; 24(4):503-10. PubMed ID: 19224453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis.
    Kornberg LJ
    Head Neck; 1998 Dec; 20(8):745-52. PubMed ID: 9790298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal adhesion kinase as potential target for cancer therapy (Review).
    Hao H; Naomoto Y; Bao X; Watanabe N; Sakurama K; Noma K; Motoki T; Tomono Y; Fukazawa T; Shirakawa Y; Yamatsuji T; Matsuoka J; Wang ZG; Takaoka M
    Oncol Rep; 2009 Nov; 22(5):973-9. PubMed ID: 19787209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances of Small Molecule Focal Adhesion Kinase (FAK) Inhibitors as Promising Anticancer Therapeutics.
    Lv P; Chen K; Zhu HL
    Curr Med Chem; 2021 Oct; 28(34):6977-6989. PubMed ID: 33797359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of focal adhesion kinase inhibitors in cancer therapy.
    Ma WW
    Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.
    Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H
    Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.